Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice

Blood Cancer Journal

Volumn 3, Issue 8, 2013, Pages

  Ikebe, E ^a   Kawaguchi, A ^b,c   Tezuka, K ^d   Taguchi, S ^a   Hirose, S ^a   Matsumoto, T ^a   Mitsui, T ^a   Senba, K ^a   Nishizono, A ^a   Hori, M ^e   Hasegawa, H ^b,f   Yamada, Y ^f   Ueno, T ^d   Tanaka, Y ^g   Sawa, H ^c   Hall, W ^h   Minami, Y ⁱ   Jeang, K T ^j   Ogata, M ^a   Morishita, K ^k   Fujisawa, J ^d   Iha, H ^a   more..

^a OITA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

^e IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^f NAGASAKI UNIVERSITY   (Japan)

^g UNIVERSITY OF THE RYUKYUS   (Japan)

^h UNIVERSITY COLLEGE DUBLIN   (Ireland)

ⁱ MAEBASHI INSTITUTE OF TECHNOLOGY   (Japan)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k UNIVERSITY OF MIYAZAKI   (Japan)

more..

Author keywords

17 DMAG; Apoptosis; ATL; Molecular chaperon; ransgenic model; Tax

Indexed keywords

ALVESPIMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL INFILTRATION; CELL TRANSFORMATION; CONTROLLED STUDY; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; T CELL LEUKEMIA; TUMOR XENOGRAFT;

EID: 84883048440     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.30     Document Type: Article

References (53)

1. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2: 725-734
2. Janssens S, Tschopp J. Signals from within: The DNA-damage-induced NF-kappaB response. Cell Death Differ 2006; 13: 773-784
3. Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009; 1: A000141
4. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344-362
5. Li XH, Fang X, Gaynor RB. Role of IKK-gamma/NEMO in assembly of the I-kappaB kinase complex. J Biol Chem 2001; 276: 4494-4500
6. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the I-kappaB kinase 2 gene. Science 1999; 284: 321-325
7. Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israel A, Rajewsky K et al. NEMO/IKK-gamma-deficient mice model incontinentia pigmenti. Mol Cell 2000; 5: 981-992
8. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 1999; 13: 1322-1328 (Pubitemid 29250199)
9. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T et al. Limb and skin abnormalities in mice lacking IKK-alpha. Science 1999; 284: 313-316 (Pubitemid 129523448)
10. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F et al. Complementation cloning of NEMO, a component of the I-kappaB kinase complex essential for NF-kappaB activation. Cell 1998; 93: 1231-1240 (Pubitemid 28307427)
11. Iha H, Kibler KV, Yedavalli VR, Peloponese JM, Haller K, Miyazato A et al. Segregation of NF-kappaB activation through NEMO/IKK-gamma by Tax and TNF-alpha: Implications for stimulus-specific interruption of oncogenic signaling. Oncogene 2003; 22: 8912-8923 (Pubitemid 38021507)
12. Chen G, Cao P, Goeddel DV. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 2002; 9: 401-410 (Pubitemid 34195564)
13. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004; 6: 97-105 (Pubitemid 38425708)
14. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475-496 (Pubitemid 32368043)
15. Hall WW, Fujii M. Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 2005; 24: 5965-5975 (Pubitemid 43086114)
16. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007; 7: 270-280 (Pubitemid 46480972)
17. Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with I-kappaB kinase gamma. J Biol Chem 1999; 274: 17402-17405
18. Carter RS, Pennington KN, Ungurait BJ, Ballard DW. In vivo identification of inducible phosphoacceptors in the IKK-gamma/NEMO subunit of human I-kappaB kinase. J Biol Chem 2003; 278: 19642-19648 (Pubitemid 36799148)
19. Lamsoul I, Lodewick J, Lebrun S, Brasseur R, Burny A, Gaynor RB et al. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus Tax oncoprotein. Mol Cell Biol 2005; 25: 10391-10406 (Pubitemid 41681963)
20. Chu ZL, DiDonato JA, Hawiger J, Ballard DW. The Tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates I-kappaB kinases containing IKK-alpha and IKK-beta. J Biol Chem 1998; 273: 15891-15894 (Pubitemid 28311350)
21. Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham Jr ET, Grant M et al. Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the I-kappaB kinase alpha (IKK-alpha) and IKK-beta cellular kinases. Mol Cell Biol 1998; 18: 5157-5165 (Pubitemid 28388099)
22. Egorin MJ, Lagattuta TF, Hamburger DR, Covey JM, White KD, Musser SM et al. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)- 17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats. Cancer Chemother Pharmacol 2002; 49: 7-19
23. Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 2006; 12: 466-472
24. Chiari E, Lamsoul I, Lodewick J, Chopin C, Bex F, Pique C. Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding. J Virol 2004; 78: 11823-11832 (Pubitemid 39390769)
25. Momose F, Naito T, Yano K, Sugimoto S, Morikawa Y, Nagata K. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J Biol Chem 2002; 277: 45306-45314 (Pubitemid 36159137)
26. Terasawa K, Minami Y. A client-binding site of Cdc37. FEBS J 2005; 272: 4684-4690 (Pubitemid 41366991)
27. Ueyama T, Kusakabe T, Karasawa S, Kawasaki T, Shimizu A, Son J et al. Sequential binding of cytosolic Phox complex to phagosomes through regulated adaptor proteins: Evaluation using the novel monomeric Kusabira-Green system and live imaging of phagocytosis. J Immunol 2008; 181: 629-640
28. Nie C, Sato K, Misawa N, Kitayama H, Fujino H, Hiramatsu H et al. Selective infection of CD4 effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/ IL-2Rgammanull mice. Virology 2009; 394: 64-72
29. Ueno S, Umeki K, Takajo I, Nagatomo Y, Kusumoto N, Umekita K et al. Proviral loads of human T-lymphotropic virus type 1 in asymptomatic carriers with different infection routes. Int J Cancer 2012; 130: 2318-2326
30. De Valck D, Jin DY, Heyninck K, Van de Craen M, Contreras R, Fiers W et al. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene 1999; 18: 4182-4190 (Pubitemid 29377849)
31. Peloponese JM, Iha H, Yedavalli VR, Miyazato A, Li Y, Haller K et al. Ubiquitination of human T-cell leukemia virus type 1 tax modulates its activity. J Virol 2005; 78: 11686-11695
32. Yan P, Qing G, Qu Z, Wu CC, Rabson A, Xiao G. Targeting autophagic regulation of NFkappaB in HTLV-I transformed cells by geldanamycin: Implications for therapeutic interventions. Autophagy 2007; 3: 600-603 (Pubitemid 350060058)
33. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Kung AL, Davies FE et al. Antimyeloma activity of heat shock protein-90 inhibition. Blood 2006; 107: 1092-1100 (Pubitemid 43156310)
34. Jeang KT, Chiu R, Santos E, Kim SJ. Induction of the HTLV-I LTR by Jun occurs through the Tax-responsive 21-bp elements. Virology 1991; 181: 218-227
35. Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 1997; 90: 65-75 (Pubitemid 28009419)
36. Meyer P, Prodromou C, Hu B, Vaughan C, Roe SM, Panaretou B et al. Structural and functional analysis of the middle segment of hsp90: Implications for ATP hydrolysis and client protein and cochaperone interactions. Mol Cell 2003; 11: 647-658 (Pubitemid 36385120)
37. Minami Y, Kimura Y, Kawasaki H, Suzuki K, Yahara I. The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo. Mol Cell Biol 1994; 14: 1459-1464 (Pubitemid 24036596)
38. Roe SM, Ali MM, Meyer P, Vaughan CK, Panaretou B, Piper PW et al. The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 2004; 116: 87-98 (Pubitemid 38156186)
39. Silverstein AM, Grammatikakis N, Cochran BH, Chinkers M, Pratt WB. p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J Biol Chem 1998; 273: 20090-20095 (Pubitemid 28377563)
40. Uozumi K. Treatment of adult T-cell leukemia. J Clin Exp Hematop 2010; 50: 9-25
41. Hasegawa H, Yamada Y, Iha H, Tsukasaki K, Nagai K, Atogami S et al. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells. Leukemia 2009; 23: 2090-2101
42. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24: 6058-6068 (Pubitemid 43086123)
43. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 2011; 27: 107-132
44. Codogno P, Mehrpour M, Proikas-Cezanne T. Canonical and non-canonical autophagy: Variations on a common theme of self-eating? Nat Rev Mol Cell Biol 2011; 13: 7-12
45. Terasawa K, Yoshimatsu K, Iemura SI, Natsume T, Tanaka K, Minami Y. Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases. Mol Cell Biol 2006; 26: 3378-3389
46. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem Sci 2006; 31: 164-172 (Pubitemid 43361923)
47. Caplan AJ, Mandal AK, Theodoraki MA. Molecular chaperones and protein kinase quality control. Trends Cell Biol 2007; 17: 87-92 (Pubitemid 46199182)
48. Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998; 93: 81-91 (Pubitemid 28173554)
49. Giam CZ, Jeang KT. HTLV-1 Tax and adult T-cell leukemia. Front Biosci 2007; 12: 1496-1507
50. Tanaka Y. Activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. Leuk Lymphoma 1999; 36: 15-23 (Pubitemid 30011624)
51. Kawaguchi A, Orba Y, Kimura T, Iha H, Ogata M, Tsuji T et al. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Blood 2009; 114: 2961-2968
52. Hertlein E, Wagner AJ, Jones J, Lin TS, Maddocks KJ, Towns III WH et al. 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: Clinical implications of HSP90 inhibition. Blood 2010; 116: 45-53
53. Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 2010; 28: 1591-1598